Call : 18015626316

Service

Cases study 3: The ability of drugs to cross the blood-brain barrier
  • 07,Apr,2025

Cases study 3: The ability of drugs to cross the blood-brain···

The brain distribution of 18F-HYMI01 …

Read More
Cases study 4: Imaging of the dopamine second receptor
  • 06,Apr,2025

Cases study 4: Imaging of the dopamine second receptor

18F-Farypride was the imaging agent …

Read More
Cases study 5: Hepatocarcinoma in situ
  • 05,Apr,2025

Cases study 5: Hepatocarcinoma in situ

Figure5: Above is a Micro-PET imaging of 18F-FDG in hepatocellular carcinoma in situ. Below is a CT ···

Read More
Cases study 6: Lung cancer in situ
  • 04,Apr,2025

Cases study 6: Lung cancer in situ

On the left, the lung of normal nude …

Read More
Cases study 7: Evaluation of tumor pharmacodynamics
  • 03,Apr,2025

Cases study 7: Evaluation of tumor pharmacodynamics

The 18F-FDG scanning imaging …

Read More